Gsk (GSK) Revenue (2009 - 2026)
Gsk (GSK) posted Revenue of $30.3 million for Q4 2015.
Gsk (GSK) has 1 years of Revenue data on file, last reported at $30.3 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 19.80 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 24.06 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 15.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 16.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 8.62 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 6.96 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.34 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 11.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.29 Bn |
| Dec 31, 2025 | 11.46 Bn |
| Sep 30, 2025 | 11.53 Bn |
| Jun 30, 2025 | 10.65 Bn |
| Mar 31, 2025 | 9.47 Bn |
| Dec 31, 2024 | 19.57 Bn |
| Sep 30, 2024 | 10.41 Bn |
| Jun 30, 2024 | 9.95 Bn |
| Mar 31, 2024 | 9.34 Bn |
| Dec 31, 2023 | 17.54 Bn |
| Sep 30, 2023 | 10.32 Bn |
| Jun 30, 2023 | 8.98 Bn |
| Mar 31, 2023 | 8.45 Bn |
| Dec 31, 2022 | 16.56 Bn |
| Sep 30, 2022 | 9.23 Bn |
| Jun 30, 2022 | 8.73 Bn |
| Mar 31, 2022 | 9.65 Bn |
| Dec 31, 2021 | 9.54 Bn |
| Sep 30, 2021 | 9.14 Bn |
| Jun 30, 2021 | 8.16 Bn |
| Mar 31, 2021 | 7.11 Bn |
| Dec 31, 2020 | 45.03 Bn |
| Jun 30, 2020 | 9.47 Bn |
| Mar 31, 2020 | 11.65 Bn |
| Dec 31, 2019 | 43.40 Bn |
| Sep 30, 2019 | 11.57 Bn |
| Jun 30, 2019 | 10.04 Bn |
| Mar 31, 2019 | 9.97 Bn |
| Dec 31, 2018 | 39.66 Bn |
| Sep 30, 2018 | 10.55 Bn |
| Jun 30, 2018 | 9.96 Bn |
| Mar 31, 2018 | 10.05 Bn |
| Dec 31, 2017 | 19.52 Bn |
| Sep 30, 2017 | 10.26 Bn |
| Jun 30, 2017 | 9.35 Bn |
| Mar 31, 2017 | 9.15 Bn |
| Dec 31, 2016 | 8.12 Bn |
| Sep 30, 2016 | 9.91 Bn |
| Jun 30, 2016 | 9.38 Bn |
| Mar 31, 2016 | 8.93 Bn |
| Dec 31, 2015 | 30.35 Mn |
| Sep 30, 2015 | 9.50 Bn |
| Jun 30, 2015 | 9.01 Bn |
| Mar 31, 2015 | 8.53 Bn |
| Dec 31, 2014 | 17.70 Bn |
| Sep 30, 2014 | 9.44 Bn |
| Jun 30, 2014 | 9.36 Bn |
| Mar 31, 2014 | 9.29 Bn |
| Dec 31, 2013 | 11.18 Bn |
| Sep 30, 2013 | 10.09 Bn |
| Jun 30, 2013 | 10.16 Bn |
| Mar 31, 2013 | 10.06 Bn |
| Dec 31, 2012 | 10.92 Bn |
| Sep 30, 2012 | 10.31 Bn |
| Jun 30, 2012 | 10.23 Bn |
| Mar 31, 2012 | 10.43 Bn |
| Dec 31, 2011 | 10.97 Bn |
| Sep 30, 2011 | 11.44 Bn |
| Jun 30, 2011 | 10.96 Bn |
| Mar 31, 2011 | 10.55 Bn |
| Dec 31, 2010 | 22.72 Bn |
| Sep 30, 2010 | 10.56 Bn |
| Jun 30, 2010 | 10.49 Bn |
| Mar 31, 2010 | 11.48 Bn |
| Dec 31, 2009 | 13.22 Bn |
| Sep 30, 2009 | 11.09 Bn |
| Jun 30, 2009 | 10.45 Bn |
| Mar 31, 2009 | 9.73 Bn |